20% Human Albumin

DRUG3 trials

Sponsors

Govind Ballabh Pant Hospital, Jesper Kjaergaard, Rigshospitalet, Denmark

Conditions

Aortic Valve DiseaseAscitesBrain InjuryCardiac ArrestCirrhosisComaCoronary DiseaseRenal Failure

Unknown Phase

Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis

SuspendedNCT00511394

Govind Ballabh Pant HospitalAscites, Cirrhosis

Start: 2007-05-31End: 2008-12-31Target: 16Updated: 2008-10-15

GLP-1 Analogs for Neuroprotection After Cardiac Arrest

CompletedNCT02442791

Jesper KjaergaardCardiac Arrest, Coma

Start: 2014-06-30End: 2016-06-30Updated: 2017-09-28

GLP-1 and Hyperoxia for Organ Protection in Heart Surgery

Active, not recruitingNCT02673931

Rigshospitalet, DenmarkAortic Valve Disease, Brain Injury, Coronary Disease +3

Start: 2016-02-29End: 2024-09-30Updated: 2024-08-28

Related Papers

Restrictive versus liberal oxygenation in patients undergoing cardiopulmonary bypass-assisted heart surgery: a randomised controlled trial.

2025-09-191 citations

Efficacy of the Glucagon-Like Peptide-1 Agonist Exenatide in Patients Undergoing CABG or Aortic Valve Replacement: A Randomized Double-Blind Clinical Trial

Circulation Cardiovascular Interventions2025-04-23

Association between inflammatory markers and survival in comatose, resuscitated out-of-hospital cardiac arrest patients

Scandinavian Cardiovascular Journal2022-05-1214 citations

Efficacy of a glucagon-like peptide-1 agonist and restrictive versus liberal oxygen supply in patients undergoing coronary artery bypass grafting or aortic valve replacement: study protocol for a 2-by-2 factorial designed, randomised clinical trial

BMJ Open2021-11-014 citations

Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest

Circulation2016-11-1353 citations

GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial

Trials2016-06-3015 citations